Skip to main content
Smart Investors Daily
BlackRock Health Sciences Trust logo

NYSE · BME

BlackRock Health Sciences Trust

Financial Services · Asset Management

$45.81

Up+$0.57 (+1.23%)

Updated Aug 25, 2026, 4:29 PM

SID Score

6.2/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
523.23M
P/E ratio
8.62
Dividend yield
6.86%
52-week range
$37.51 – $46.38
Volume
34.44K
Avg. volume
50.34K

Price performance

BME price history

1M range · 21 trading sessions · Daily adjusted prices

BME closed at $45.81 after 21 trading sessions, up 6.19% for the selected period.

Last close
$45.81
Period change
+6.19%
Period low
$43.14
Period high
$46.13
Daily close
View OHLC price history
BME OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 24, 2026$46.26$46.26$45.65$45.8134.44K
Aug 21, 2026$45.72$46.3751$45.71$46.1361.47K
Aug 20, 2026$45.74$46.1699$45.64$45.8068.19K
Aug 19, 2026$45.20$45.72$45.00$45.6347.8K
Aug 18, 2026$44.64$44.98$44.50$44.8635.26K
Aug 17, 2026$44.11$44.45$44.10$44.4023.88K
Aug 14, 2026$44.14$44.26$44.0253$44.1429.23K
Aug 13, 2026$44.89$44.9799$44.38$44.5531.07K
Aug 12, 2026$44.78$44.9588$44.44$44.6745.8K
Aug 11, 2026$44.57$44.99$44.45$44.6235.45K
Aug 10, 2026$44.12$44.46$44.0171$44.3864.27K
Aug 7, 2026$43.64$44.12$43.53$44.1154.73K
Aug 6, 2026$43.65$43.77$43.3101$43.5029.29K
Aug 5, 2026$43.46$43.71$43.23$43.4546.93K
Aug 4, 2026$43.47$43.48$43.0589$43.1855.89K
Aug 3, 2026$43.53$43.6142$43.21$43.5045.08K
Jul 31, 2026$43.55$43.74$43.0099$43.4985.02K
Jul 30, 2026$43.80$44.01$43.20$43.5370.33K
Jul 29, 2026$43.86$44.33$43.765$44.0430.53K
Jul 28, 2026$43.43$43.96$43.18$43.8762.91K
Jul 27, 2026$43.21$43.35$42.96$43.1432.23K

Latest BME news

The latest Smart Investors Daily articles mentioning BME.

BME research

Overview

Company profile and research snapshot.

Company profile

Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.